Chengdu Olymvax Biopharmaceuticals (688319.SHG) Q2 2021 Earnings

25AugExpected
Q2 2021
0.05
0.39
0.72
1.05

Details

Expected EPS
N/A
Actual EPS
0.0541
Surprise EPS
0.05
Surprise Percent
+∞%

Description

Chengdu Olymvax Biopharmaceuticals (688319.SHG) has reported earnings of 0.0541 per share for Q2 2021.

0 Comments

Share your thoughts